In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Abbott Laboratories shows a significant implied upside of 51%, with high-confidence valuations clustering between $108 and $160, indicating potential undervaluation. Strong profitability and leverage contrast with low growth, heightening risk despite good liquidity and efficiency scores. Monte Carlo simulations reveal wide volatility and 35% downside risk beneath the current price.